Sverica International to acquire CFWH

NewsGuard 100/100 Score

The Center for Wound Healing, Inc. (OTCBB: CFWH), a leading manager of comprehensive wound care treatment centers that offer wound care and hyperbaric oxygen therapy, today announced that it has entered into a definitive agreement to be acquired by Sverica International, a leading private equity firm, for approximately $41 million.

Under terms of the agreement, which has been unanimously approved by CFWH's board of directors, CFWH shareholders will receive $0.60 in cash, subject to certain adjustments, for each share of CFWH common stock they hold, representing a 140% premium over the $0.25 closing price on October 5, 2010. The cash amount that CFWH shareholders will be entitled to receive under the agreement, giving effect to all possible adjustments, will be at least $0.579 per share.

Completion of the transaction is subject to customary closing conditions, including CFWH shareholder approval, and the receipt by Sverica of financing for the transaction in accordance with financing commitments received. Holders of approximately 68% of CFWH's outstanding common stock have executed a voting agreement under which they have agreed to vote their shares in favor of approval of the proposed acquisition.

The transaction is expected to be completed in the fourth quarter of 2010, subject to customary closing conditions.

Gleacher & Company Securities, Inc. and Butzel Long, a professional corporation, acted as financial and legal advisors, respectively, to The Center for Wound Healing, Inc.'s Board of Directors.

Source:

The Center for Wound Healing, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Investigating dosage in hyperbaric oxygen therapy for post-covid conditions